Position in DNLI
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$356,684
+$121,024 QoQ
Shares Held
13,868
+13.0% QoQ
Ownership
0.009%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#169
of 290 holders
Holding Since
Dec 2020
7 quarters on record
Voting authority
Sole 1%
Shared 0%
None 99%
Common Shares in DNLI Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026LPL Financial LLC holds $551,304,275 across 203 Biotechnology names. DNLI ranks #113 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
289,111 | $143,610,107 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
65,755 | $41,000,872 | |
| 3 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
310,761 | $25,330,129 | |
| 4 | ARGX |
Argenx SE
|
19,499 | $18,090,587 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
57,890 | $17,426,626 | |
| 6 | HALO |
Halozyme Therapeutics, Inc.
|
203,557 | $15,932,406 | |
| 7 | RPRX |
Royalty Pharma plc
|
249,117 | $13,967,990 | |
| 8 | INSM |
INSMED Inc
|
128,553 | $13,706,320 |
All Filings in DNLI
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $356,684 | 13,868 | Shares | Sole | 2026-08-07 | |
| 2026-03-31 | $235,660 | 12,274 | Shares | Sole | 2026-05-06 | |
| 2025-12-31 | $173,421 | 10,504 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $154,608 | 10,648 | Shares | Sole | 2025-11-12 | |
| 2024-03-31 | $699,424 | 34,085 | Shares | Sole | 2024-05-10 | |
| 2021-06-30 | $256,185 | 3,266 | Shares | Sole | 2021-08-13 | |
| 2020-12-31 | $294,751 | 3,519 | Shares | Sole | 2021-02-12 | |
| No filing history on record for this holder in this stock. | ||||||